Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lundbeck Antipsychotic Sertindole Suspended From U.K. Market

Executive Summary

Lundbeck's antipsychotic sertindole has been suspended from the U.K. market "due to concerns about reports of cardiac arrhythmias and sudden cardiac arrest," the U.K. Committee for the Safety of Medicines told prescribers Dec. 2.
Advertisement

Related Content

Support For Serdolect In Specific Patients, But Panel Can’t Define Population
Support For Serdolect In Specific Patients, But Panel Can’t Define Population
Lundbeck Serlect NDA Revival Is One Project For CEO-Elect Braestrup
Lundbeck Serlect NDA Revival Is One Project For CEO-Elect Braestrup
Advertisement
UsernamePublicRestriction

Register

PS033255

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel